Skip to content
Sign in

COR · NYSE

Cencora (COR) Stock Price & Fundamentals

$531.26−0.34%−$1.83End-of-day price as of Oct 9, 2026

Cencora (COR) closed at $531.26 on Oct 9, 2026, down 0.34% from the previous close of $533.09.

Share price, past year

1Y +25.41%

52-week range $408.36 – $563.69. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$531.26
Sep 30, 2026$537.69
Aug 31, 2026$537.59
Jul 31, 2026$529.56
Jun 30, 2026$543.46
May 29, 2026$542.19
Apr 30, 2026$528.22
Mar 31, 2026$491.68
Feb 27, 2026$450.11
Jan 30, 2026$423.80
Dec 31, 2025$436.06
Nov 28, 2025$435.03
Oct 31, 2025$434.53

Key statistics

Market cap
$101.38B
P/E (TTM)
39.4
EPS (TTM)
$13.47
Revenue (TTM)
$332.77B
Net income (TTM)
$2.62B
Shares outstanding
190.8M
Dividend yield
0.44%
52-week range
$408.36 – $563.69

Cencora's market cap is $101.38B, based on a share price of $531.26 and 190.8M shares outstanding as of Jun 30, 2026.

Financials

Cencora reported revenue of $321.33B for fiscal 2025, up 9.31% from fiscal 2024.

Cencora earned net income of $1.55B in fiscal 2025, a net margin of 0.5%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Cencora annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Sep 30, 2025$321.33B+9.3%$1.55B0.5%$7.96$3.21B
FY2024ended Sep 30, 2024$293.96B+12.1%$1.51B0.5%$7.53$3.00B
FY2023ended Sep 30, 2023$262.17B+9.9%$1.75B0.7%$8.53$3.45B
FY2022ended Sep 30, 2022$238.59B+11.5%$1.70B0.7%$8.04$2.21B
FY2021ended Sep 30, 2021$213.99B+12.7%$1.54B0.7%$7.39$2.23B
FY2020ended Sep 30, 2020$189.89B+5.7%−$3.41B−1.8%−$16.65$1.84B
FY2019ended Sep 30, 2019$179.59B+6.9%$855.37M0.5%$4.04$2.03B
FY2018ended Sep 30, 2018$167.94B+9.7%$1.66B1.0%$7.53$1.07B
FY2017ended Sep 30, 2017$153.14B+4.3%$364.48M0.2%$1.64$1.04B
FY2016ended Sep 30, 2016$146.85B—$1.43B1.0%$6.32$2.71B
Cencora quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q3 FY2026ended Jun 30, 2026$84.75B$763.52M$3.94
Q2 FY2026ended Mar 31, 2026$78.36B$1.64B$8.40
Q1 FY2026ended Dec 31, 2025$85.93B$559.65M$2.87
Q4 FY2025ended Sep 30, 2025$83.73B−$339.70M−$1.74
Q3 FY2025ended Jun 30, 2025$80.66B$687.40M$3.52
Q2 FY2025ended Mar 31, 2025$75.45B$717.87M$3.68
Q1 FY2025ended Dec 31, 2024$81.49B$488.60M$2.50
Q4 FY2024ended Sep 30, 2024$79.05B$3.38M$0.04

Company profile

Name
Cencora, Inc.
Ticker
COR
Exchange
NYSE
Industry (SEC SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Headquarters
1 West First Avenue, Conshohocken, PA 19428
Incorporated in
DE
Fiscal year ends
September
SEC CIK
0001140859

Recent SEC filings

Frequently asked questions

What is Cencora's stock price?

Cencora (COR) closed at $531.26 on Oct 9, 2026, down 0.34% from the previous close of $533.09.

What is Cencora's market cap?

Cencora's market cap is $101.38B, based on a share price of $531.26 and 190.8M shares outstanding as of Jun 30, 2026.

How much revenue does Cencora make?

Cencora reported revenue of $321.33B for fiscal 2025, up 9.31% from fiscal 2024.

What is COR's P/E ratio?

Cencora's price-to-earnings ratio is 39.4, based on trailing twelve-month diluted EPS of $13.47.

Does Cencora pay a dividend?

Yes. Cencora declared $2.35 per share in dividends over the last four quarters, a yield of 0.44%.

Sources and methodology

Fundamentals come from Cencora, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures